Compare Exelon Corporation Common Stock (EXC) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelon Corporation Common Stock vs Inovio Pharmaceuticals Inc — how do they compare? Exelon Corporation Common Stock trades at $41.73 (market cap $42.99B), while Inovio Pharmaceuticals Inc trades at $1.15 (market cap $112.19M). The key difference: Exelon Corporation Common Stock is far larger — about 383.2× Inovio Pharmaceuticals Inc's market cap, and Exelon Corporation Common Stock pays a 4.03% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| EXC | INO | |
|---|---|---|
Market Cap | $42.99B | $112.19M |
Volume | 7,570,408 | 3,201,278 |
Sector | Utilities | Health |
52-Week High | $50.29 | $2.65 |
52-Week Low | $40.20 | $0.66 |
Enterprise Value | $93.85B | $83.51M |
Dividend Yield | 4.03% | — |
Typical Hold Time | — | 43 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INO trades at $1.15, down 0.43% on the day, with a bearish technical signal from moving averages and oscillators. The company shows consistent quarterly earnings beats but operates at significant losses with a -130,000% net income margin and negative cash flow. Key catalyst is the FDA's October 30, 2026 PDUFA date for INO-3107, with analyst consensus leaning bullish at a $2.75 price target.
The investment case hinges on FDA approval of INO-3107, offering substantial upside from current levels. However, persistent cash burn, minimal revenue, and high valuation multiples relative to sales pose significant risks. Investors face binary outcomes driven by regulatory decisions and commercialization execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Exelon Corporation Common Stock
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
